SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-24-129503
Filing Date
2024-11-21
Accepted
2024-11-21 08:55:33
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 pro_supp_nov_2024_rd.htm 424B5 932885
2 GRAPHIC img100593884_0.jpg GRAPHIC 33760
3 GRAPHIC img100593884_1.jpg GRAPHIC 33760
4 GRAPHIC img100593884_2.jpg GRAPHIC 33760
  Complete submission text file 0000950170-24-129503.txt   1067604
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-277758 | Film No.: 241482271
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)